PRDM14 expression was also significantly negatively correlated with lymphocyte infiltration in tumors (ρ = −0.52, P < 0.001): PRDM14-negative breast cancer tissues exhibited increased numbers of tumor-infiltrating cytotoxic T lymphocytes (CD3+CD8+CD16–). Here, PRDM14 is linked to breast cancer.